Skip to main content
Erschienen in: World Journal of Urology 1/2017

30.04.2016 | Original Article

American Confederation of Urology (CAU) experience in minimally invasive partial nephrectomy

verfasst von: Fernando P. Secin, Octavio A. Castillo, José J. Rozanec, Marcelo Featherston, Pablo Holst, José Cocisfran Alves Milfont, Patricio García Marchiñena, Alberto Jurado Navarro, Anamaría Autrán, Agustín R. Rovegno, Oscar Rodríguez Faba, Joan Palou, Victor Teixeira Dubeux, Luciano Nuñez Bragayrac, Rene Sotelo, Stenio Zequi, Gustavo Cardoso Guimarães, Mario Álvarez-Maestro, Luis Martínez-Piñeiro, Gustavo Villoldo, Alberto Villaronga, Diego Abreu Clavijo, Ricardo Decia, Rodrigo Frota, Ivar Vidal-Mora, Diana Finkelstein, Juan I. Monzó Gardiner, Oscar Schatloff, Andres Hernández-Porrás, Félix Santaella-Torres, Emilio T. Quesada, Rodolfo Sánchez-Salas, Hugo Dávila, Humberto Villavicencio Mavric

Erschienen in: World Journal of Urology | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To describe the perioperative and oncology outcomes in a series of laparoscopic or robotic partial nephrectomies (PN) for renal tumors treated in diverse institutions of Hispanic America from the beginning of their minimally invasive (MI) PN experience through December 2014.

Methods

Seventeen institutions participated in the CAU generated a MI PN database. We estimated proportions, medians, 95 % confidence intervals, Kaplan–Meier curves, multivariate logistic and Cox regression analyses. Clavien–Dindo classification was used.

Results

We evaluated 1501 laparoscopic (98 %) or robotic (2 %) PNs. Median age: 58 years. Median surgical time, warm ischemia and intraoperative bleeding were 150, 20 min and 200 cc. 81 % of the lesions were malignant, with clear cell histology being 65 % of the total. Median maximum tumor diameter is 2.7 cm, positive margin is 8.2 %, and median hospitalization is 3 days. One or more postoperative complication was recorded in 19.8 % of the patients: Clavien 1: 5.6 %; Clavien 2: 8.4 %; Clavien 3A: 1.5 %; Clavien 3B: 3.2 %; Clavien 4A: 1 %; Clavien 4B: 0.1 %; Clavien 5: 0 %. Bleeding was the main cause of a reoperation (5.5 %), conversion to radical nephrectomy (3 %) or open partial nephrectomy (6 %). Transfusion rate is 10 %. In multivariate analysis, RENAL nephrometry score was the only variable associated with complications (OR 1.1; 95 % CI 1.02–1.2; p = 0.02). Nineteen patients presented disease progression or died of disease in a median follow-up of 1.37 years. The 5-year progression or kidney cancer mortality-free rate was 94 % (95 % CI 90, 97). Positive margins (HR 4.98; 95 % CI 1.3–19; p = 0.02) and females (HR 5.6; 95 % CI 1.7–19; p = 0.005) were associated with disease progression or kidney cancer mortality after adjusting for maximum tumor diameter.

Conclusion

Laparoscopic PN in these centers of Hispanic America seem to have acceptable perioperative complications and short-term oncologic outcomes.
Literatur
1.
Zurück zum Zitat Mathew A, Devesa SS, Fraumeni JF Jr, Chow WH (2002) Global increases in kidney cancer incidence, 1973–1992. Eur J Cancer Prev 11:171–178CrossRefPubMed Mathew A, Devesa SS, Fraumeni JF Jr, Chow WH (2002) Global increases in kidney cancer incidence, 1973–1992. Eur J Cancer Prev 11:171–178CrossRefPubMed
2.
Zurück zum Zitat Ljungberg B, Cowan NC, Hanbury DC et al (2010) EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 58:398–406CrossRefPubMed Ljungberg B, Cowan NC, Hanbury DC et al (2010) EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 58:398–406CrossRefPubMed
3.
Zurück zum Zitat Kaushik D, Kim SP, Childs MA et al (2013) Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors. Eur Urol 64:600–606CrossRefPubMed Kaushik D, Kim SP, Childs MA et al (2013) Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors. Eur Urol 64:600–606CrossRefPubMed
4.
Zurück zum Zitat Mitchell RE, Gilbert SM, Murphy AM, Olsson CA, BensonMC McKiernan JM (2006) Partial nephrectomy and radical nephrectomy offer similar cancer outcomes in renal cortical tumors 4 cm or larger. Urology 67:260–264CrossRefPubMed Mitchell RE, Gilbert SM, Murphy AM, Olsson CA, BensonMC McKiernan JM (2006) Partial nephrectomy and radical nephrectomy offer similar cancer outcomes in renal cortical tumors 4 cm or larger. Urology 67:260–264CrossRefPubMed
5.
Zurück zum Zitat Scherr DS, Ng C, Munver R, Sosa RE, Vaughan ED Jr, Del Pizzo J (2003) Practice patterns among urologic surgeons treating localized renal cell carcinoma in the laparoscopic age: technology versus oncology. Urology 62:1007–1011CrossRefPubMed Scherr DS, Ng C, Munver R, Sosa RE, Vaughan ED Jr, Del Pizzo J (2003) Practice patterns among urologic surgeons treating localized renal cell carcinoma in the laparoscopic age: technology versus oncology. Urology 62:1007–1011CrossRefPubMed
6.
Zurück zum Zitat Castillo Cádiz O, Sánchez-Salas R, Vidal Moral I, Albino GD, Díaz MC, Vitagliano G, Pinto IG, Fonerón AV (2008) Nefrectomía radical laparoscópica. Nuestra experiencia en 150 pacientes consecutivos. Rev Chil de Cir 60:297–302 Castillo Cádiz O, Sánchez-Salas R, Vidal Moral I, Albino GD, Díaz MC, Vitagliano G, Pinto IG, Fonerón AV (2008) Nefrectomía radical laparoscópica. Nuestra experiencia en 150 pacientes consecutivos. Rev Chil de Cir 60:297–302
7.
Zurück zum Zitat Rozanec JJ, Ameri C, Gueglio G (2010) Nefrectomía parcial: sí, ¿abierta o laparoscópica? Rev Argent de Urol 75:2–5 Rozanec JJ, Ameri C, Gueglio G (2010) Nefrectomía parcial: sí, ¿abierta o laparoscópica? Rev Argent de Urol 75:2–5
8.
Zurück zum Zitat Monzó JI, García MF, Manzur E, Schell J, Finkelstein D, Albornoz J, Eraso M, Ortega R, Secin FP (2011) Experiencia inicial en cirugía laparoscópica asistida por robot en un servicio de urología de un hospital público. Rev Argent de Urol 76:46–55 Monzó JI, García MF, Manzur E, Schell J, Finkelstein D, Albornoz J, Eraso M, Ortega R, Secin FP (2011) Experiencia inicial en cirugía laparoscópica asistida por robot en un servicio de urología de un hospital público. Rev Argent de Urol 76:46–55
9.
Zurück zum Zitat García Marchiñena PA, BillordoPeres N, Bergero MA, Jurado Navarro AM, Tobía González I, Damia O, Gueglio G (2012) Resultados funcionales de la cirugía renal conservadora: comparación entre dos técnicas. Rev Argent de Urol 77:76–81 García Marchiñena PA, BillordoPeres N, Bergero MA, Jurado Navarro AM, Tobía González I, Damia O, Gueglio G (2012) Resultados funcionales de la cirugía renal conservadora: comparación entre dos técnicas. Rev Argent de Urol 77:76–81
10.
Zurück zum Zitat Rozanec JJ, Featherston M, Holst P, Ares J, Vallone C, Grassi A, Nolazco A (2012) Evolución del tiempo de isquemia en 130 nefrectomías parciales laparoscópicas. Rev Argent de Urol 77:184–190 Rozanec JJ, Featherston M, Holst P, Ares J, Vallone C, Grassi A, Nolazco A (2012) Evolución del tiempo de isquemia en 130 nefrectomías parciales laparoscópicas. Rev Argent de Urol 77:184–190
11.
Zurück zum Zitat Kutikov A, Uzzo RG (2009) The RENAL nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 182:844–853CrossRefPubMed Kutikov A, Uzzo RG (2009) The RENAL nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 182:844–853CrossRefPubMed
12.
Zurück zum Zitat Sobin L, Gospodarowicz M, Wittekind C (2009) for the International Union Against Cancer (IUAC) TNM classification of malignant tumors, 7th edn. Blackwell, New York Sobin L, Gospodarowicz M, Wittekind C (2009) for the International Union Against Cancer (IUAC) TNM classification of malignant tumors, 7th edn. Blackwell, New York
13.
Zurück zum Zitat Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655–663CrossRefPubMed Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655–663CrossRefPubMed
14.
Zurück zum Zitat Clavien PA, Strasberg SM (2009) Severity grading of surgical complications. Ann Surg 250:197–198CrossRefPubMed Clavien PA, Strasberg SM (2009) Severity grading of surgical complications. Ann Surg 250:197–198CrossRefPubMed
15.
Zurück zum Zitat Huang WC, Levey AS, Serio AM, Snyder M, Vickers AJ, Raj GV, Scardino PT, Russo P (2006) Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 7:735–740CrossRefPubMedPubMedCentral Huang WC, Levey AS, Serio AM, Snyder M, Vickers AJ, Raj GV, Scardino PT, Russo P (2006) Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 7:735–740CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Russo P, Huang W (2008) The medical and oncological rationale for partial nephrectomy for the treatment of T1 renal cortical tumors. Urol Clin North Am 35:635–643CrossRefPubMed Russo P, Huang W (2008) The medical and oncological rationale for partial nephrectomy for the treatment of T1 renal cortical tumors. Urol Clin North Am 35:635–643CrossRefPubMed
17.
Zurück zum Zitat Weight CJ, Larson BT, Fergany AF et al (2010) Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J Urol 183:1317–1323CrossRefPubMed Weight CJ, Larson BT, Fergany AF et al (2010) Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J Urol 183:1317–1323CrossRefPubMed
18.
Zurück zum Zitat Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305CrossRefPubMed Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305CrossRefPubMed
19.
Zurück zum Zitat Patel SG, Penson DF, Pabla B et al (2012) National trends in the use of partial nephrectomy: a rising tide that has not lifted all boats. J Urol 187:816–821CrossRefPubMed Patel SG, Penson DF, Pabla B et al (2012) National trends in the use of partial nephrectomy: a rising tide that has not lifted all boats. J Urol 187:816–821CrossRefPubMed
20.
Zurück zum Zitat Hollenbeck BK, Taub DA, Miller DC, Dunn RL, Wei JT (2006) National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? Urology 67:254–259CrossRefPubMed Hollenbeck BK, Taub DA, Miller DC, Dunn RL, Wei JT (2006) National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? Urology 67:254–259CrossRefPubMed
21.
Zurück zum Zitat Kim SP, Shah ND, Weight CJ et al (2011) Contemporary trends in nephrectomy for renal cell carcinoa in the United States: results from a population based cohort. J Urol 186:1779–1785CrossRefPubMed Kim SP, Shah ND, Weight CJ et al (2011) Contemporary trends in nephrectomy for renal cell carcinoa in the United States: results from a population based cohort. J Urol 186:1779–1785CrossRefPubMed
22.
Zurück zum Zitat Thompson RH, Kaag M, Vickers A et al (2009) Contemporary use of partial nephrectomy at a tertiary care center in the United States. J Urol 181:993–997CrossRefPubMedPubMedCentral Thompson RH, Kaag M, Vickers A et al (2009) Contemporary use of partial nephrectomy at a tertiary care center in the United States. J Urol 181:993–997CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Gill IS, Kavoussi LR, Lane BR, Blute ML, Babineau D, Colombo JR Jr, Frank I, Permpongkosol S, Weight CJ, Kaouk JH, Kattan MW, Novick AC (2007) Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 178:41–46CrossRefPubMed Gill IS, Kavoussi LR, Lane BR, Blute ML, Babineau D, Colombo JR Jr, Frank I, Permpongkosol S, Weight CJ, Kaouk JH, Kattan MW, Novick AC (2007) Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 178:41–46CrossRefPubMed
24.
Zurück zum Zitat Borghesi M, Brunocilla E, Schiavina R, Martorana G (2013) Positive surgical margins after nephron-sparing surgery for renal cell carcinoma: incidence, clinical impact, and management. Clin Genitourin Cancer 11:5–9CrossRefPubMed Borghesi M, Brunocilla E, Schiavina R, Martorana G (2013) Positive surgical margins after nephron-sparing surgery for renal cell carcinoma: incidence, clinical impact, and management. Clin Genitourin Cancer 11:5–9CrossRefPubMed
25.
Zurück zum Zitat Marszalek M, Carini M, Chlosta P, Jeschke K, Kirkali Z, Knüchel R, Madersbacher S, Patard JJ, Van Poppel H (2012) Positive surgical margins after nephron-sparing surgery. Eur Urol 61:757–763CrossRefPubMed Marszalek M, Carini M, Chlosta P, Jeschke K, Kirkali Z, Knüchel R, Madersbacher S, Patard JJ, Van Poppel H (2012) Positive surgical margins after nephron-sparing surgery. Eur Urol 61:757–763CrossRefPubMed
26.
Zurück zum Zitat Moore LE, Wilson RT, Campleman SL (2005) Lifestyle factors, exposures, genetic susceptibility, and renal cell cancer risk: a review. Cancer Invest 23:240–255CrossRefPubMed Moore LE, Wilson RT, Campleman SL (2005) Lifestyle factors, exposures, genetic susceptibility, and renal cell cancer risk: a review. Cancer Invest 23:240–255CrossRefPubMed
27.
Zurück zum Zitat Zisman A, Pantuck AJ, Dorey F, Chao DH, Gitlitz BJ, Moldawer N, Lazarovici D, deKernion JB, Figlin RA, Belldegrun AS (2002) Mathematical model to predict individual survival for patients with renal cell carcinoma. J Clin Oncol 20:1368–1374CrossRefPubMed Zisman A, Pantuck AJ, Dorey F, Chao DH, Gitlitz BJ, Moldawer N, Lazarovici D, deKernion JB, Figlin RA, Belldegrun AS (2002) Mathematical model to predict individual survival for patients with renal cell carcinoma. J Clin Oncol 20:1368–1374CrossRefPubMed
28.
Zurück zum Zitat Simmons MN, Gill IS (2007) Decreased complications of contemporary laparoscopic partial nephrectomy: use of a standardized reporting system. J Urol 177:2067–2073CrossRefPubMed Simmons MN, Gill IS (2007) Decreased complications of contemporary laparoscopic partial nephrectomy: use of a standardized reporting system. J Urol 177:2067–2073CrossRefPubMed
29.
Zurück zum Zitat Carneiro A, Sivaraman A, Sanchez-Salas R, Di Trapani E, Barret E, Rozet F, Galiano M, Pizzaro FU, Doizi S, Cathala N, Mombet A, Prapotnich D, Cathelineau X (2015) Evolution from laparoscopic to robotic nephron sparing surgery: a high-volume laparoscopic center experience on achieving ‘trifecta’ outcomes. World J Urol 33:2039–2044CrossRefPubMed Carneiro A, Sivaraman A, Sanchez-Salas R, Di Trapani E, Barret E, Rozet F, Galiano M, Pizzaro FU, Doizi S, Cathala N, Mombet A, Prapotnich D, Cathelineau X (2015) Evolution from laparoscopic to robotic nephron sparing surgery: a high-volume laparoscopic center experience on achieving ‘trifecta’ outcomes. World J Urol 33:2039–2044CrossRefPubMed
30.
Zurück zum Zitat Baumert H, Ballaro A, Shah N, Mansouri D, Zafar N, Molinié V, Neal D (2007) Reducing warm ischaemia time during laparoscopic partial nephrectomy: a prospective comparison of two renal closure techniques. Eur Urol 52:1164–1169CrossRefPubMed Baumert H, Ballaro A, Shah N, Mansouri D, Zafar N, Molinié V, Neal D (2007) Reducing warm ischaemia time during laparoscopic partial nephrectomy: a prospective comparison of two renal closure techniques. Eur Urol 52:1164–1169CrossRefPubMed
Metadaten
Titel
American Confederation of Urology (CAU) experience in minimally invasive partial nephrectomy
verfasst von
Fernando P. Secin
Octavio A. Castillo
José J. Rozanec
Marcelo Featherston
Pablo Holst
José Cocisfran Alves Milfont
Patricio García Marchiñena
Alberto Jurado Navarro
Anamaría Autrán
Agustín R. Rovegno
Oscar Rodríguez Faba
Joan Palou
Victor Teixeira Dubeux
Luciano Nuñez Bragayrac
Rene Sotelo
Stenio Zequi
Gustavo Cardoso Guimarães
Mario Álvarez-Maestro
Luis Martínez-Piñeiro
Gustavo Villoldo
Alberto Villaronga
Diego Abreu Clavijo
Ricardo Decia
Rodrigo Frota
Ivar Vidal-Mora
Diana Finkelstein
Juan I. Monzó Gardiner
Oscar Schatloff
Andres Hernández-Porrás
Félix Santaella-Torres
Emilio T. Quesada
Rodolfo Sánchez-Salas
Hugo Dávila
Humberto Villavicencio Mavric
Publikationsdatum
30.04.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 1/2017
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-016-1837-z

Weitere Artikel der Ausgabe 1/2017

World Journal of Urology 1/2017 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.